Assembly Biosciences
ASMB26.5350.36% ( +0.095 )
Assembly Biosciences (ASMB)
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-a...
- Open
- 26.320
- High
- 26.915
- Low
- 26.180
- Prev. Close
- 26.440
- Volume
- 113.35K
- Turnover
- 3.00M
- Avg Price
- 26.507
- Bid/Ask Ratio
- --
- Amplitude
- 2.78%
- 52wk High
- 39.705
- Volume Ratio
- 0.87
- Turnover Ratio
- 1.09%
Assembly Biosciences Analyst Rating
View MoreForecast & Rating
Jun 12, 2026Price forecast
$50.0088.43%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jun 12 at 02:15 PM
Mizuho Securities Keeps Their Buy Rating on Assembly Biosciences (ASMB)
- Market Beat · Jun 5 at 02:03 PM
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands
- TradingView · May 23 at 02:13 AM
Key facts: Assembly Biosciences Offers; ABI-6250 Expanded to PBC/PSC
- nasdaq · May 22 at 07:55 AM
Assembly Reports Pricing Of $100 Mln Registered Offering
- rttnews · May 22 at 07:44 AM
Assembly Biosciences Prices 3.35 Mln Shares At $26.50/shr; To Expand ABI-6250 Development; Stock Up
- MSN · May 22 at 06:53 AM
Assembly Biosciences prices $100M equity offering
